THE INTEL DESK
Breaking reports from the network. Every card is an open file.
Taiwan Strait: Beijing Moves Third Carrier Group Into Contested Waters as Washington Weighs Response
Satellite imagery reviewed by this office shows the PLA Navy has repositioned its Fujian carrier group within 180 nautical miles of Taiwanese territorial waters. Pentagon sources confirm a corresponding shift in the USS Gerald R. Ford strike group's patrol pattern.
NSC Split: White House Divided on Sanctions Package as European Allies Break Ranks
A classified procurement memo obtained this week reveals deep fractures within the National Security Council over the next round of sanctions targeting Chinese technology firms.
The Quad Is Dead. Here Is What Replaces It — and Why Beijing Is Already Two Moves Ahead
The Indo-Pacific strategic framework that Washington spent years building has quietly been replaced by something more targeted, more bilateral, and far less visible.
$14.2 Billion Hypersonic Contract Quietly Reshuffled: Three Primes In, Two Out — Here Is Who Won
The Army's Long-Range Hypersonic Weapon program has been restructured in a closed session of the Senate Armed Services Committee, with major implications for the defense-industrial base.
Pentagon Accelerates Dark Eagle Timeline by 14 Months: What It Signals for the Missile Defense Supply Chain
A classified procurement memo reveals the Army's Long-Range Hypersonic Weapon program will reach initial operational capability in Q2 — more than a year ahead of publicly stated schedule.
The F-35 Sustainment Crisis Nobody Is Talking About — and the $400B Question Behind It
Sustainment costs for the F-35 fleet have quietly surpassed every projection the Pentagon has published. The four-hundred-billion-dollar question is who pays for the fix.
The $6,200 Cancer Drug That Costs $14 to Manufacture: Inside the Pricing Anatomy of Oncology's Dirtiest Secret
A line-by-line cost analysis of one of America's most prescribed oncology drugs reveals a markup structure that would be illegal in 22 countries.
FDA Fast-Track Denied: A Promising Alzheimer's Compound Blocked After Lobbying Surge From Three Major Patent Holders
A promising Alzheimer's compound that showed significant results in Phase II trials has been denied fast-track designation following an unprecedented lobbying campaign.
Medicare Negotiation Fallout: Five Drug Classes Where Prices Will Shift — and What Smart Money Is Doing Now
The first round of Medicare drug price negotiations is producing ripple effects across five major drug classes. Institutional investors are already repositioning.
APT41 Targeting Defense Primes: Inside the Campaign That Breached Three Tier-1 Contractors in 90 Days
A Chinese state-sponsored threat group has successfully penetrated the networks of three major defense contractors in a coordinated campaign lasting less than ninety days.
Pentagon Approves First Autonomous Targeting Authority for Naval Drone Swarms — the AI Firms Behind the Code
A Deputy Secretary of Defense directive grants Task Force 59 the authority to operate autonomous surface vessels under conditional engagement rules without a human in the loop.
The Chip Blockade Is Failing: How Beijing Built a Parallel Semiconductor Pipeline — and Who Profits
Despite export controls, Chinese semiconductor firms have constructed an alternative supply chain that is now producing chips at nodes previously considered beyond their reach.
Between the Lines: What the Fed's April Statement Actually Told Institutional Traders — In Three Words
Three words buried in the Federal Reserve's latest statement have triggered a quiet repositioning among institutional traders that retail investors have not yet noticed.
Central Banks Bought More Gold in Q1 Than Any Quarter Since 1967. Here Is the Strategy They Are Not Announcing.
Central bank gold purchases in the first quarter shattered records dating back nearly six decades. The pattern reveals a coordinated de-dollarization strategy.
The Dollar's Quiet Slide: Why Smart Money Is Rotating Into Hard Assets — and What Retail Investors Are Missing
The dollar index has lost ground in seven of the last nine sessions, but the real story is what institutional money is buying with the proceeds.